Headinvest »

Alnylam Pharmaceuticals shares owned by Headinvest

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Headinvest from 13F filings

Historical chart of Headinvest investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Headinvest consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Headinvest

Quarter filed Position value Share count Share price at filing
2025-09-30 $228k 500 456.00

More positions owned by Headinvest

Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Large Cap Etf (VV)
Vanguard Whitehall Fds High Div Yld (VYM)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Oracle Corporation (ORCL)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
American Express Company (AXP)
Intuit (INTU)
Vanguard Index Fds Mid Cap Etf (VO)
Wal-Mart Stores (WMT)
Vanguard Specialized Funds Div App Etf (VIG)

View all positions for Headinvest

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals